Cargando…
Treatment of evolving cancers will require dynamic decision support
Cancer research has traditionally focused on developing new agents, but an underexplored question is that of the dose and frequency of existing drugs. Based on the modus operandi established in the early days of chemotherapies, most drugs are administered according to predetermined schedules that se...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688269/ https://www.ncbi.nlm.nih.gov/pubmed/37777307 http://dx.doi.org/10.1016/j.annonc.2023.08.008 |